104 results
iWatch: Not so fast Apple
The lure of wearable technology and its application to health is tremendous- so tremendous that even the richest company on the planet-Apple, can’t resist it apparently. And so goes the recent insider news that has captured the attention of people worldwide “Apple is developing software and sensors that can predict heart attacks”. Not so fast Apple, not so fast….
What mobile diagnostics can do for the rest of the 90%
Consider the cell phone.
As an engine of change, it is a romantically disruptive one, a technology that crisscrosses borders and thrives on connection in all its forms – to networks, to people, to the world. Already, in areas of Africa and India, mobile phones play every part at once, bankers and pharmacists and secretaries rolled into one. In developing countries, the path of least resistance to modernization is flung up one phone tower at a time. They have taken a platform we have spent on Angry Birds and advertisements, and woven a way of life.
Posted on 16.10.2013
Always read the small print…on the ENVI proposal for the reprocessing of single-use medical devices
Caveat Emptor, or ‘Buyer Beware’, is a commercial rule favouring the seller, now largely extinct due to modern consumer legislation. But the European Parliament’s ENVI Committee, in its amendment on the reprocessing of single-use medical devices, has unwittingly slipped something similar back in again. Given the complex and highly technical nature of the Medical Devices Directives, I can see where busy MEPs would struggle to understand the details and consequences of this amendment, so I think it is essential that we take a moment to read the fine print.
Posted on 15.10.2013
Beyond rhetoric: MEPs need facts to make an informed decision on medical devices regulation
Europe’s medical device industry has always agreed that Europe’s regulatory system for devices needs to be improved and has put forward various proposals to achieve this. In the wake of a case of fraud like the PIP breast implant incident, it is clear that we need a safer system that makes sure Europe’s patients continue to have timely access to the latest life-saving and life-enhancing medical technologies.
Posted on 28.08.2013
How One Diagnostic Test Can Save Billions of Euros Per Year
In the past, percussion of the abdomen, taking temperature, or tasting sugar in urine were considered diagnostic standard of care methodologies. Today, invitro diagnostics (IVD) provide additional objective biomarkers that diagnose cancer, infections, heart attacks and many other health conditions.
Boosting Personalised Medicine – A Patient Perspective
Hockey, sailing, golf, football … As an avid sports fan, I used to enjoy all those kinds of activities with great enthusiasm – until the day I became paralysed. Some of you may remember me from the European MedTech Forum in 2011 or from this video on which I told my story after I made my comeback. For those who don’t: my name is Hylke Sieders, I am 37 and suffered from a sudden spinal cord bleeding between the C2 and C3 vertebrae (in the neck) in 2009 which left me almost entirely paralysed. Almost, since I am able to stretch my arms and use 3 ½ fingers from my left hand. But I don’t have movement in the rest of my body although my legs are not completely devoid of sensation (current status C5-C6).
Medtech as a cost driver… or not?
Nowadays everyone seems convinced of the clinical benefits that medical technologies, devices and diagnostics, bring to the table. Many even recognise that our innovations bring about considerable socio-economic benefits. And yet, in the end I hear the same thing over and over again: medical technology drives the rise in healthcare expenditure.
EDMA and Eucomed have always refuted this claim and now we have research by the European Health Technology Institute (EHTI) which basically confirms two of our points of view:
Medical devices and in vitro diagnostics proposals: Information is Power
World Health Day approaching us on April 7th is meant to raise awareness on the endless host of hurdles that undermines our health and therefore, our quality of life. Public health is about making sure that the external factors that determine our health are governed by policies that have people’s well-being at the very heart of their mandate. EPHA, Europe’s leading NGO advocating for better health, is committed to that very principle.
This year marks EPHA’s 20th anniversary in advocating EU and European policy-makers on public health. Bringing today’s leaders to focus on people’s health is not an easy task. The medical devices and in vitro diagnostics files appropriately represent the juggling effort that advocating for public health usually turns out to be.
Posted on 13.03.2013
Tailored Tools for Diagnosing Heart Failure
As the 2013 World Salt Awareness Week calls for “Less Salt, Please”, it may be time for Europeans to seriously consider the implications of their seasoning habits on their health, notably their heart health. Heart failure (HF) is characterised by the inability of the heart to respond to the blood flow demands of the body, a condition that is becoming increasingly common, with more than 20 million directly affected worldwide.